HELX Holdings Information

HELX is an equity ETF with a total of 64 individual holdings. The top holdings are Guardant Health stock at 8.91%, Natera at 6.85%, Krystal Biotech at 5.78%, United Therapeutics at 4.02%, and Ligand Pharmaceuticals at 3.83%.

Total Holdings

Top 10 Percentage

44.82%

Asset Class

Equity

ETF Category

Health

Assets

23.02M

PE Ratio

29.40

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GH	Guardant Health, Inc.	8.91%	15,718
2	NTRA	Natera, Inc.	6.85%	7,131
3	KRYS	Krystal Biotech, Inc.	5.78%	4,418
4	UTHR	United Therapeutics Corporation	4.02%	1,680
5	LGND	Ligand Pharmaceuticals Incorporated	3.83%	3,794
6	BBIO	BridgeBio Pharma, Inc.	3.50%	12,192
7	ADPT	Adaptive Biotechnologies Corporation	3.23%	48,245
8	LLY	Eli Lilly and Company	3.04%	639
9	LON: AZN	AstraZeneca PLC	2.92%	3,695
10	VRTX	Vertex Pharmaceuticals Incorporated	2.76%	1,435
11	INSM	Insmed Incorporated	2.76%	5,932
12	KRX: 207940	Samsung Biologics Co.,Ltd.	2.62%	652
13	CTVA	Corteva, Inc.	2.35%	6,904
14	n/a	Cash	2.25%	513,378
15	ALNY	Alnylam Pharmaceuticals, Inc.	2.19%	1,687
16	TWST	Twist Bioscience Corporation	2.14%	7,184
17	TVTX	Travere Therapeutics, Inc.	2.13%	10,758
18	MEDP	Medpace Holdings, Inc.	2.09%	1,053
19	IONS	Ionis Pharmaceuticals, Inc.	2.07%	6,258
20	TEM	Tempus AI, Inc.	2.02%	8,726
21	NBIX	Neurocrine Biosciences, Inc.	2.01%	2,840
22	REGN	Regeneron Pharmaceuticals, Inc.	1.97%	748
23	EBR: ARGX	argenx SE	1.68%	459
24	BNTX	BioNTech SE	1.55%	3,860
25	VCYT	Veracyte, Inc.	1.54%	7,261

Showing 25 of 64 holdings

Subscribe to see the full list

Activate Now

As of May 31, 2026